 |
|
|
With health care reform initiatives, quality measurement, and requirements for much greater accountability to numerous stakeholder groups, new questions arise constantly that need to be answered with more depth and greater insight.
Healthcare companies operate in an industry having truly unique challenges like long product development life cycles, regulated environments of different countries, complex market dynamics, etc. Our reports help these organizations to make informed business decisions in this increasingly challenging business environment.
We specialize in high-level information processing and analysis, specific to the needs of Healthcare and related industries worldwide. These reports contain analytical as well as statistical information on Healthcare industry. We thoroughly analyze new vistas being opened by the strongly growing healthcare industry like Telemedicine, Healthcare IT, Medical Devices, Medical Tourism, Health Insurance, E Health and Hospital Services.
 |
| UK Generics Market Analysis |
| Apr, 2011 | Pages : 55 |
| The generics market in the UK is anticipated to grow at a CAGR of around 16% during 2011-2013 and will be worth GBP 6.5 Billion by 2013 end....
read more |
|
Buy Now
US$ 800.00
|
|
 |
| US Stem Cell Market Analysis |
| Apr, 2011 | Pages : 65 |
| With growing usage of stem cells in drugs development and increased government funding, the stem cell market is projected to grow at a CAGR of around 45% during 2011-2013....
read more |
|
Buy Now
US$ 800.00
|
|
 |
| Booming US Generic Drug Market |
| Mar, 2011 | Pages : 60 |
| The US generics market is anticipated to grow at a CAGR of around 10% during 2010-2013, with growth largely fuelled by the emergence of new products as patents of branded drugs are getting expired......
read more |
|
Buy Now
US$ 1000.00 800.00
|
|
 |
| Global Contract Manufacturing Market Analysis |
| Mar, 2011 | Pages : 70 |
| With the changing economic scenario and the pressure of reducing drugs manufacturing cost, the global contract manufacturing market is expected to grow at a CAGR of around 11% during 2011-2013......
read more |
|
Buy Now
US$ 1500.00 1200.00
|
|
|
 |
| Japanese Generic Market Forecast to 2013 |
| Mar, 2011 | Pages : 45 |
| Backed by patent expiration of blockbuster drugs and active ingredients such as anastrozole, telmisartan, etc., generics market is projected to grow at a CAGR of around 8% during 2009-2013......
read more |
|
Buy Now
US$ 800.00 400.00
|
|
 |
| Russian Pharma Sector Forecast to 2013 |
| Mar, 2011 | Pages : 100 |
| Double-digit growth in all the three segments is expected to propel the Russian pharmaceutical market to grow at a CAGR of around 13% during 2011-2013, earning around RUB 856 Billion in revenue......
read more |
|
Buy Now
US$ 800.00
|
|
 |
| Diabetes Market in UAE |
| Feb, 2011 | Pages : 35 |
| Amid increasing spending and prevalence of diabetes, the diabetes market in the country is anticipated to grow at a CAGR of 10% during 2011-2013…...
read more |
|
Buy Now
US$ 800.00 600.00
|
|
 |
| Emerging Biotech Sector in Malaysia |
| Feb, 2011 | Pages : 90 |
| The biotech market in Malaysia reached to the mark of RM 663 Million (US$ 212 Million) in 2010 and is likely to grow at a CAGR of around 16% to reach RM 885 Million (US$ 283 Million) by 2012…...
read more |
|
Buy Now
US$ 1100.00 800.00
|
|
|
|
|
|
|
|
|
 |
|
|